IMVAMUNE

This brand name is authorized in Canada

Active ingredients

The drug IMVAMUNE contains one active pharmaceutical ingredient (API):

1 Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) UNII JDS6958QAG - VACCINIA VIRUS

Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. Read about Smallpox, live attenuated

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMVAMUNE Suspension for injection	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BX	Other viral vaccines	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines
Discover more medicines within J07BX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02416638